Drug profile · INN
aspirin
ASTRIX
aspirin (ASTRIX) is a cyclooxygenase inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — aspirin
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 20
- Programs
- 114
- Data quality
- 0.89
Quick answer
aspirin (ASTRIX) is a cyclooxygenase inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
| NMPA | clinical trials | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Related patents
-
US 12383540
Compounds that modulates AMPA receptor function
granted -
US 12298319
Method for measuring alpha value of muscarinic M1 receptor positive allosteric modulators
granted -
US 12274710
Compound for regulating body weight imbalance, composition thereof and application thereof
granted -
US 12129476
Methods for measuring the potency of AADC viral vectors
granted -
US 12084670
Regulating alkaloids
granted -
US 11865155
Plant extract obtained from Morus plant leaves which has an IC50 value to inhibit a-glucosidase I at a concentration of less than 90 uG/ml, compositions containing same, method of extraction and uses thereof
granted -
US 11667924
Increasing levels of nicotinic alkaloids in plants
granted -
US 11572568
Regulating alkaloids
granted -
US 11298345
Compounds that modulates AMPA receptor function
granted -
US 11186567
AMPA receptor potentiators
granted -
US 11090349
Plant extract obtained from Morus plant leaves, compositions containing same, method of extraction and uses thereof
granted -
US 11083696
Dispersion anaesthetic device
granted -
US 10907170
Increasing levels of nicotinic alkaloids in plants
granted -
US 10829774
Increasing levels of nicotinic alkaloids in plants
granted -
US 10731172
Regulating alkaloids
granted -
US 10564161
Method for identifying a bacterial infection
granted -
US 10287596
Regulating alkaloids
granted -
US 10209255
Method for identifying a bacterial infection
granted -
US 10190129
Increasing levels of nicotinic alkaloids in plants
granted -
US 10184931
Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
granted
Frequently asked questions
What is aspirin?
aspirin (ASTRIX) is a cyclooxygenase inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for aspirin?
ASTRIX is a marketed brand name for aspirin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of aspirin?
aspirin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.